Hualan Biological Engineering
002007.SZ
#3268
Rank
HK$27.83 B
Marketcap
HK$15.22
Share price
-3.08%
Change (1 day)
-34.30%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): HK$2.10 B

According to Hualan Biological Engineering's latest financial reports the company's current earnings (TTM) are HK$2.09 B. In 2023 the company made an earning of HK$2.28 B an increase over its 2022 earnings that were of HK$1.64 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$2.10 B-8.05%
2023 HK$2.28 B39.21%
2022 HK$1.64 B-19.12%
2021 HK$2.03 B-17.9%
2020 HK$2.47 B37.11%
2019 HK$1.80 B11.71%
2018 HK$1.61 B50.84%
2017 HK$1.07 B1.1%
2016 HK$1.05 B23.49%
2015 HK$0.85 B8.37%
2014 HK$0.79 B10.83%
2013 HK$0.71 B54.56%
2012 HK$0.46 B-17.03%
2011 HK$0.55 B-41.34%
2010 HK$0.94 B6.15%
2009 HK$0.89 B261.3%
2008 HK$0.24 B85.75%
2007 HK$0.13 B49.27%
2006 HK$89.24 M56.98%
2005 HK$56.85 M34.28%
2004 HK$42.33 M